Atazanavir Sulfate Patent Expiration
Atazanavir Sulfate is Used for treating HIV-1 infection. It was first introduced by Bristol Myers Squibb Co
Atazanavir Sulfate Patents
Given below is the list of patents protecting Atazanavir Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Reyataz | US5849911 | Antivirally active heterocyclic azahexane derivatives |
Jun 20, 2017
(Expired) | Bristol Myers Squibb |
| Reyataz | US5849911 | Antivirally active heterocyclic azahexane derivatives |
Jun 20, 2017
(Expired) | Bristol Myers Squibb |
| Reyataz |
US5849911 (Pediatric) | Antivirally active heterocyclic azahexane derivatives |
Dec 20, 2017
(Expired) | Bristol Myers Squibb |
| Reyataz | US6087383 | Bisulfate salt of HIV protease inhibitor |
Dec 21, 2018
(Expired) | Bristol Myers Squibb |
| Reyataz | US6087383 | Bisulfate salt of HIV protease inhibitor |
Dec 21, 2018
(Expired) | Bristol Myers Squibb |
| Reyataz |
US6087383 (Pediatric) | Bisulfate salt of HIV protease inhibitor |
Jun 21, 2019
(Expired) | Bristol Myers Squibb |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Atazanavir Sulfate Generics
Several generic applications have been filed for Atazanavir Sulfate. The first generic version for Atazanavir Sulfate was by Teva Pharmaceuticals Usa and was approved on Apr 22, 2014. And the latest generic version is by Hetero Labs Ltd Unit Iii and was approved on Feb 2, 2022.
Given below is the list of companies who have filed for Atazanavir Sulfate generic.
1. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Sep 24, 2018 |
| EQ 200MG BASE | capsule | Discontinued | ORAL | N/A | Sep 24, 2018 |
| EQ 300MG BASE | capsule | Discontinued | ORAL | N/A | Sep 24, 2018 |
2. CIPLA
Cipla Ltd has filed for 4 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 200MG BASE | capsule | Discontinued | ORAL | N/A | Aug 9, 2018 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Aug 9, 2018 |
| EQ 300MG BASE | capsule | Discontinued | ORAL | N/A | Aug 9, 2018 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Aug 9, 2018 |
3. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Apr 22, 2014 |
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Apr 22, 2014 |
| EQ 200MG BASE | capsule | Prescription | ORAL | AB | Apr 22, 2014 |
| EQ 300MG BASE | capsule | Prescription | ORAL | AB | Apr 22, 2014 |
4. AMNEAL
Amneal Eu Ltd has filed for 4 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2020 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Jun 1, 2020 |
| EQ 200MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2020 |
| EQ 300MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2020 |
5. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 3 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Feb 2, 2022 |
| EQ 200MG BASE | capsule | Prescription | ORAL | AB | Feb 2, 2022 |
| EQ 300MG BASE | capsule | Prescription | ORAL | AB | Feb 2, 2022 |
6. LAURUS
Laurus Labs Ltd has filed for 3 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Laurus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | capsule | Prescription | ORAL | AB | Apr 30, 2021 |
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Apr 30, 2021 |
| EQ 200MG BASE | capsule | Prescription | ORAL | AB | Apr 30, 2021 |
7. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Jun 4, 2020 |
| EQ 200MG BASE | capsule | Discontinued | ORAL | N/A | Jun 4, 2020 |
| EQ 300MG BASE | capsule | Discontinued | ORAL | N/A | Jun 4, 2020 |
8. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Atazanavir Sulfate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Jun 25, 2018 |
| EQ 200MG BASE | capsule | Prescription | ORAL | AB | Jun 25, 2018 |
| EQ 300MG BASE | capsule | Prescription | ORAL | AB | Jun 25, 2018 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jun 25, 2018 |